The Petri Dish: Ginkgo, Pfizer sign $331M deal; Leqembi OK’d in Japan


Pfizer is partnering up with Boston synthetic biology firm Ginkgo Bioworks, plus other life sciences news you may have missed.

Previous Cincinnati-based Gries Financial Partners acquires Dayton investment firm Capital Portfolio Advisors
Next University of Maryland Medical Center, UMd. medical school to revamp philanthropic efforts